| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-31 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-08-31 |
|---|---|---|---|
| Revenue (Total Sales) | $659.1M | $584.3M | $661.9M |
| YoY Revenue Growth % | +12.8% | -11.7% | — |
| Gross Profit | $210.8M | $191.1M | — |
| Gross Margin % | 32.0% | 32.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $88.1M | $76.6M | $102.2M |
| Operating Margin % | 13.4% | 13.1% | 15.4% |
| Net Income (GAAP) | $74.1M | $66.3M | $72.4M |
| EBITDA (Normalized) | $122.1M | $99.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $132.9M | $95.8M | $119.7M |
| Capital Expenditures (CapEx) | $42.5M | $29.0M | — |
| Free Cash Flow (FCF) | $90.4M | $66.8M | $119.7M |
| FCF Margin % | 13.7% | 11.4% | 18.1% |
| Return on Invested Capital (ROIC %) | 16.1% | 14.8% | — |
| Cash & Short-Term Equivalents | $199.6M | $194.1M | — |
| Total Debt (Short + Long Term) | $114.8M | $114.9M | — |
| Total Stockholders' Equity | $518.2M | $488.5M | — |